Related references
Note: Only part of the references are listed.Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study
J. Peltola et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy
A. Schreiner et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Antiepileptic monotherapy significantly impairs normative scores on common tests of executive functions
E. Hessen et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Strategies to detect adverse effects of antiepileptic drugs in clinical practice
M. Carreno et al.
EPILEPSY & BEHAVIOR (2008)
The impact of seizures and adverse effects on global health ratings
Joyce A. Cramer et al.
EPILEPSY & BEHAVIOR (2007)
Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?
G. Zaccara et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugs
S. G. Uijl et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2006)
New onset geriatric epilepsy - A randomized study of gabapentin, lamotrigine, and carbamazepine
AJ Rowan et al.
NEUROLOGY (2005)
Complaints associated with the use of antiepileptic drugs: results from a community-based study
JA Carpay et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2005)
Adverse effects of antiepileptic drugs
E Perucca et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
The new antiepileptic drugs - Scientific review
SM LaRoche et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Systematic screening allows reduction of adverse antiepileptic drug effects - A randomized trial
FG Gilliam et al.
NEUROLOGY (2004)
Drug selection for the newly diagnosed patient: When is a new generation antiepileptic drug indicated?
T Tomson
JOURNAL OF NEUROLOGY (2004)
Seizure reduction and quality of life improvements in people with epilepsy
GL Birbeck et al.
EPILEPSIA (2002)
Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation
JA Cramer et al.
EPILEPSY RESEARCH (2001)
The impact of epilepsy from the patient's perspective II: views about therapy and health care
RS Fisher et al.
EPILEPSY RESEARCH (2000)
Patient satisfaction with polypharmacy reduction in chronic epileptics
M Matsuura
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2000)